<?xml version='1.0' encoding='utf-8'?>
<document id="2751276"><sentence text="Inhibition of enoxacin absorption by antacids or ranitidine."><entity charOffset="14-22" id="DDI-PubMed.2751276.s1.e0" text="enoxacin" /><entity charOffset="49-59" id="DDI-PubMed.2751276.s1.e1" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.2751276.s1.e0" e2="DDI-PubMed.2751276.s1.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s1.e0" e2="DDI-PubMed.2751276.s1.e1" /></sentence><sentence text="Ten normal volunteers participated in a randomized, five-way crossover study to determine the effect of concurrent enoxacin and antacid or ranitidine administration on enoxacin absorption"><entity charOffset="115-123" id="DDI-PubMed.2751276.s2.e0" text="enoxacin" /><entity charOffset="139-149" id="DDI-PubMed.2751276.s2.e1" text="ranitidine" /><entity charOffset="168-176" id="DDI-PubMed.2751276.s2.e2" text="enoxacin" /><pair ddi="false" e1="DDI-PubMed.2751276.s2.e0" e2="DDI-PubMed.2751276.s2.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s2.e0" e2="DDI-PubMed.2751276.s2.e1" /><pair ddi="false" e1="DDI-PubMed.2751276.s2.e0" e2="DDI-PubMed.2751276.s2.e2" /><pair ddi="false" e1="DDI-PubMed.2751276.s2.e1" e2="DDI-PubMed.2751276.s2.e1" /><pair ddi="false" e1="DDI-PubMed.2751276.s2.e1" e2="DDI-PubMed.2751276.s2.e2" /></sentence><sentence text=" The bioavailability of a single oral 400-mg enoxacin dose was significantly decreased, by 73 and 49%, when Maalox TC was administered 0"><entity charOffset="45-53" id="DDI-PubMed.2751276.s3.e0" text="enoxacin" /></sentence><sentence text="5 and 2 h before enoxacin, respectively"><entity charOffset="17-25" id="DDI-PubMed.2751276.s4.e0" text="enoxacin" /></sentence><sentence text=" Enoxacin bioavailability was not significantly altered when the antacid was given 8 h before or 2 h after enoxacin administration"><entity charOffset="1-9" id="DDI-PubMed.2751276.s5.e0" text="Enoxacin" /><entity charOffset="107-115" id="DDI-PubMed.2751276.s5.e1" text="enoxacin" /><pair ddi="false" e1="DDI-PubMed.2751276.s5.e0" e2="DDI-PubMed.2751276.s5.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s5.e0" e2="DDI-PubMed.2751276.s5.e1" /></sentence><sentence text=" Ranitidine, administered intravenously 2 h before enoxacin, also significantly decreased enoxacin bioavailability, by 40%"><entity charOffset="1-11" id="DDI-PubMed.2751276.s6.e0" text="Ranitidine" /><entity charOffset="51-59" id="DDI-PubMed.2751276.s6.e1" text="enoxacin" /><entity charOffset="90-98" id="DDI-PubMed.2751276.s6.e2" text="enoxacin" /><pair ddi="false" e1="DDI-PubMed.2751276.s6.e0" e2="DDI-PubMed.2751276.s6.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s6.e0" e2="DDI-PubMed.2751276.s6.e1" /><pair ddi="false" e1="DDI-PubMed.2751276.s6.e0" e2="DDI-PubMed.2751276.s6.e2" /><pair ddi="false" e1="DDI-PubMed.2751276.s6.e1" e2="DDI-PubMed.2751276.s6.e1" /><pair ddi="false" e1="DDI-PubMed.2751276.s6.e1" e2="DDI-PubMed.2751276.s6.e2" /></sentence><sentence text=" The correlation between the proximity of antacid administration and the magnitude of the decrease in enoxacin bioavailability supports complexation as the mechanism of the antacid-enoxacin interaction"><entity charOffset="102-110" id="DDI-PubMed.2751276.s7.e0" text="enoxacin" /><entity charOffset="181-189" id="DDI-PubMed.2751276.s7.e1" text="enoxacin" /><pair ddi="false" e1="DDI-PubMed.2751276.s7.e0" e2="DDI-PubMed.2751276.s7.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s7.e0" e2="DDI-PubMed.2751276.s7.e1" /></sentence><sentence text=" However, reduction of enoxacin bioavailability by ranitidine suggests that elevated gastric pH may also play a role in the antacid-enoxacin drug-drug interaction"><entity charOffset="23-31" id="DDI-PubMed.2751276.s8.e0" text="enoxacin" /><entity charOffset="51-61" id="DDI-PubMed.2751276.s8.e1" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.2751276.s8.e0" e2="DDI-PubMed.2751276.s8.e0" /><pair ddi="false" e1="DDI-PubMed.2751276.s8.e0" e2="DDI-PubMed.2751276.s8.e1" /></sentence><sentence text="" /></document>